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Abstract: The objective of this work was the development of a methodology capable of simultaneously
determine 26 mycotoxins in mixed feed rations collected in 20 dairy farms. A sample preparation
methodology based on a combination of (d)SPE and QuEChERS extractions was used. Liquid
chromatography-high resolution mass spectrometry was employed for both identification and
quantification purposes. To this respect, a powerful workflow based on data-independent acquisition,
consisting of fragmenting all precursor ions entering the mass spectrometer in narrow m/z isolation
windows (SWATH), was implemented. SWATH data file then contains all the information that
would be acquired in a multitude of different experimental approaches in a single all-encompassing
dataset. Analytical method performance was evaluated in terms of linearity, repeatability and
matrix effect. Relative recoveries were also measured, giving values above 80% for most compounds.
Matrix-matched calibration was carried out and enabled reaching the low ng mL−1 level for many
mycotoxins. The observed matrix effect, in most cases suppressive, reached even values higher
than 60%. The repeatability was also adequate, showing a relative standard deviation lower than
10%. All unified samples analyzed showed co-occurrence of two or more mycotoxins, recurrently
zearalenone, fumonisin B1, and β-zearalenol, with an occurrence frequency ranging from 60% to 90%.
Keywords: Mycotoxins; mixed feed rations; QuEChERS; dispersive solid phase extraction; liquid
chromatography; high-resolution mass spectrometry; data independent SWATH
Key Contribution: The optimized analytical methodology, based on QuEChERS with (d)SPE clean-up
and HPLC-HRMS analysis by means of SWATH mode, allowed the identification and quantification
of 26 mycotoxins in 97 mixed ration samples collected in 20 dairy farms (NW Spain). Fumonisins
B1 and B2, zearalenone and its metabolite β-zearalenol, cyclopiazonic acid and enniatin B were
the mycotoxins most frequently found. All samples showed co-occurrence of two or more of these
mycotoxins, recurrently zearalenone and fumonisin B1. None of the samples showed concentrations
higher than the maximum values established for feed intended for dairy cows.
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1. Introduction
Mycotoxins are natural secondary metabolites produced by various filamentous fungi, mainly
belonging to Aspergillus, Penicillium, and Fusarium genera. Around 400 of these metabolites are
identified and classified, being the most predominant zearalenone, ochratoxin A, fumonisins and
trichothecenes [1]. Mycotoxins can be produced during all stages; from pre-harvest, when plants are
growing, to storage, transport or further processing [2].
Mycotoxins can cause some adverse effect on animal and human health. They can be carcinogenic
agents (aflatoxin B1 (AFB1), fumonisins B1 and B2, (FB1 and FB2)), present estrogenic activity (zearalenone
(ZEA)), or teratogenic (ochratoxin A, (OTA)) and immunotoxinogenic effects (deoxynivalenol, (DON)) [3].
In consequence, the presence and intake of mycotoxins can also strongly reduce animal productivity in
farms. The severity of the damage depends on the compound, the degree of exposure and the possible
co-occurrence of various mycotoxins. This is a frequent situation, such is the case with zearalenone and
deoxynivalenol or zearalenone/deoxynivalenol/nivalenol/fumonisin B1 [4].
Most studies concerning mycotoxins occurrence were carried out in food matrices, cereals [5–8]
feedstuff [1,9,10], plant based beverages [11], and ruminant milk [12]. Nonetheless, some researchers
also found traces of these toxins in human breast milk [13,14]. Due to mycotoxins stability to high
temperatures and persistence during food preparation procedures [15], they present a risk to the whole
food chain.
With the purpose of protecting consumers against mycotoxin intake, maximum levels of aflatoxins
(AFB1, and sum of AFB1, AFB2, AFG1, and AFG2), sum of FB1 and FB2, DON, OTA, and ZEA, were
established by the European Union for products intended for animal feeding [16,17]. In 2013, maximum
recommended levels were set for the sum of toxins T-2 and HT-2 in cereals, as well [18].
Due to the hazard mycotoxins may cause, sensitive and selective analytical techniques are needed
for their monitoring in food and feed. Besides, because of their frequent co-occurrence, the European
Food Safety Authority (EFSA) recommends multianalyte methodologies. Nevertheless, finding an
appropriate methodology, in terms of sample preparation, for a wide number of mycotoxins can be a
tough task due to the structural variety and different chemical properties of the compounds.
Many sample treatment procedures for the simultaneous determination of multiple mycotoxins
have been published. From classic approaches like solid liquid extraction (SLE) and liquid–liquid
extraction (LLE) to the most recent ones, like modified Quick, Easy, Cheap, Effective, Rugged,
and Safe (QuEChERS) extraction or matrix solid-phase dispersion (MSPD). Modified QuEChERS
procedure is the sample pre-treatment of choice in many recent publications, due to its simplicity and
cost-efficiency [8,9,19,20].
In the case of food and feed samples, clean-up steps are usually needed in order to reduce the
matrix effect, especially in the case of liquid chromatography analyses. Solid phase extraction (SPE)
and dispersive solid phase extraction (dSPE) are the most used as described in literature [19,21–23].
In terms of analysis, two different approaches are currently employed to control the presence
of mycotoxins in food and feed. For screening and semi-quantitative analysis, enzyme-linked
immune-sorbent assay (ELISA) and thin-layer chromatography (TLC) are the most frequently used. To
provide accurate quantitative information and therefore reduce the number of possible false-positive
results, chromatographic techniques such as gas chromatography (GC) and high-performance liquid
chromatography (HPLC) coupled to ultraviolet (UV), fluorescence (FL), and mass spectrometry (MS)
detectors are used [24,25].
HPLC coupled to tandem mass spectrometry (MS/MS) is considered the most reliable technique in
order to achieve high specificity and sensitivity for the simultaneous determination of a large number
of mycotoxins, reaching low limits of detection (LOD) and quantification (LOQ). Several studies
using this technique for the analysis of multi-mycotoxins in food and feed commodities have been
published [9,10,12,26,27].
More recently, high-resolution mass spectrometry (HRMS) has been implemented either in Data
Dependent Acquisition mode or in Data Independent Acquisition mode. Besides providing high
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specificity and resolution due to the use of the accurate mass, HRMS allows for performing non-target
screening. Quadrupole time-of-flight (QTOF) instruments offer the advantages of TOF detectors in
terms of resolution and the possibility of acquiring product ion spectra working in MS/MS mode
using accurate mass. This feature provides additional confirmatory parameters besides retention
time and ion fragment ratio, i.e., exact mass, isotope pattern and spectral comparison against spectra
libraries with smart confirmation criteria. Among the applications published employing quadrupole
time-of-flight and Orbitrap® detectors [1,19,28,29] for the mycotoxin analysis in food and feed, the
main part of them use Orbitrap technique.
Hence, the aim of this work was to develop a methodology that allowed the simultaneous analysis
of multi-class mycotoxins in mixed rations. A QuEChERS extraction method was implemented, with
the addition of a clean-up step based on solid phase extraction and dispersive solid phase extraction,
in order to minimize the effect of the matrix. The analytical methodology was carried out using HPLC
followed by triple quadrupole-time-of-flight detection based on a data independent workflow.
The method was optimized and validated for 26 mycotoxins produced by different genera.
Several analytical parameters, such as linearity, repeatability, accuracy, matrix effect, measurement
uncertainties, limits of detection, and recovery, were evaluated.
A monitoring of these mycotoxins was carried out using the proposed methodology analyzing 97
mixed ration samples collected in 20 dairy farms from Galicia (NW Spain) over one year. These rations
may constitute the basis of the diet for dairy cows during 6 to 8 months of the year.
2. Results and Discussion
2.1. Chromatographic Analysis
The aim of this work was to develop an analytical methodology based on high performance liquid
chromatography coupled to triple quadrupole-time of flight mass spectrometry for the simultaneous
analysis of the 26 mycotoxins. Hence, the chromatographic conditions were optimized to achieve an
efficient separation of the target compounds (see conditions in the Experimental section). The initial
step was to consider the ionization of the target mycotoxins by injection of a standard containing all
analytes, both in positive and negative mode. This allows for the selection of the most sensitive mode
for each compound.
Two runs were needed for each analysis, since the methodology does not allow switching from
one ionization mode to the other in such short time.
Different mobile phase configurations were evaluated. Being the solvents used always water as
aqueous phase and methanol as organic phase, two different buffers were tested (ammonium formate
and ammonium acetate, 3 mM), as well as the addition of an acidic component (formic acid and
acetic acid, 0.1% v/v). The regression equations for matrix-matched calibration using each mobile
phase configurations are specified in Tables S1 and S2. As shown, although the slopes obtained using
ammonium acetate and ammonium formate did not present great differences, some frequently found
compounds gave better responses using ammonium acetate rather than ammonium formate. Such
is the case of deoxynivalenol acetylated derivatives (3+15-ADON), FB2, cyclopiazonic acid (CPA) or
alternariol (AOH) (examples in Figure 1). Besides, the addition of an acidic component (formic or acetic
acid) caused a substantial signal suppression in almost all cases in comparison with the mobile phase
without acid. Exceptionally, few compounds such as andrastin A (AND A), and toxins T-2 and HT-2
gave better responses with the addition of 0.1% of acid. Therefore, the mobile phase configuration
selected was a combination of water (A) and methanol (B), both containing 3 mM ammonium acetate.
The method performance will be then assessed with this mobile phase composition.
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Figure 1. Response comparisons between the four mobile phase compositions: ammonium acetate 
3mM, ammonium formate 3 mM and the addition of acetic or formic acid 0.1%, respectively for (a) 
3+15 acetyldeoxynivalenol; (b) cyclopiazonic acid; and (c) alternariol. 
The proposed chromatographic method offers a complete separation of all 26 mycotoxins and a 
good peak shape for quantification. 
The only two exceptions were the isomers 3-DON and 15-DON for which the sum of the two 
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Thus, to achieve a reliable detection and quantification of mycotoxins, and exhaustive analytical 
methodology is needed, beginning with a matrix effect evaluation. Most publications working with 
this kind of matrix emphasized the need of a matrix-matched calibration in order to properly evaluate 
the concentration of the analytes [1,21]. For this purpose, a comparison was made between a matrix-
matched standard calibration and an external calibration prepared in MeOH. The concentration 
range values covered depended on the mycotoxin, but in all cases, the range was of two orders of 
magnitude (see individual ranges of concentration in Table 1) with eight concentration levels. Matrix-
matched calibration was performed using the sample with the lowest analyte content found (blank 
sample), spiked in the same range of concentrations as for the external calibration. For most 
compounds, the signal showed a suppressive effect when working with matrix (Figure 2), showing a 
median value of −35%, with some compounds (e.g., HT-2 toxin and AOH) exhibiting over 70% of 
signal suppression. However, there were a few examples of signal enhancement, such as the case of 
FB1 and FB2. Because of this variance, further studies and quantification were carried out using the 
matrix-matched approach. 
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2.2. ethod Performance Evaluation
Mixed ration is a difficult matrix to work with because of the complexity of its composition. Thus,
to achieve a reliable detection and quantification of mycotoxins, and exhaustive analytical methodology
is needed, beginning with a matrix effect evaluation. Most publications working with this kind of matrix
emphasized the need of a matrix-matched calibration in order to properly evaluate the concentration
of the analytes [1,21]. For this purpose, a comparison was made between a matrix-matched standard
calibration and an external calibration prepared in MeOH. The concentration range values covered
depended on the mycotoxin, but in all cases, the range was of two orders of magnitude (see individual
ranges of concentration in Table 1) with eight concentration levels. Matrix-matched calibration was
performed using the sample with the lowest analyte content found (blank sample), spiked in the same
range of concentrations as for the external calibration. For most compounds, the signal showed a
suppressive effect when working with matrix (Figure 2), showing a median value of −35%, with some
compounds (e.g., HT-2 toxin and AOH) exhibiting over 70% of signal suppression. However, there
were a few examples of signal enhancement, such as the case of FB1 and FB2. Because of this variance,
further studies and quantification were carried out using the matrix-matched approach.
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Table 1. HPLC-Triple time-of-flight (TOF) performance for the mycotoxin analysis: linearity, intra and inter-day precision, detection limits, recovery and matrix effect.
Compounds R2
Linear
Range
(ng mL−1)
Intra-Day
Precision
(%) (n = 3)
Inter-Day
Precision
(%) (n = 3)
LOQs
(ng mL−1)
Recoveries
Matrix
Effect (%)Concentration
(ng mL−1)
Recovery (%) (%
RSD)
Concentration
(ng mL−1)
Recovery (%) (%
RSD)
3+15-ADON 0.9998 10.7–1828.3 2.4 5.8 24 339.6 85.8 (3.9) 95.4 90.5 (3.0) −0.6
DON 0.9999 26.7–912.8 2.4 6.2 41.1 169.6 114.2 (0.8) 47.7 121.9 (8.7) −22.4
ENN B 0.9999 40.6–905.4 2.5 5.9 46.8 168.2 88.8 (4.1) 47.6 132.6 (5.8) 33.9
ENN B1 1.0000 13.5–479.7 1.1 1.4 24 170.6 58.3 (1.2) 47.9 67.4 (3.5) −29.6
FB1 0.9996 2.7–92.6 1.7 5.2 2.9 17.2 92.7 (2.2) 4.8 29.6 (6.6) 195.3
FB2 0.9998 1.3–85.8 0.2 0.4 2.4 15.9 118.1 (0.3) 4.5 98.7 (4.2) 197.8
HT-2 0.9998 1.1–190.7 2.3 2.2 3.3 35.4 98.9 (0.4) 10.0 61.3 (2.0) −69.8
MAC A 0.9998 2.6–87.9 3.1 6.0 4.2 16.3 104.0 (5.5) 4.6 70.4 (2.9) −51.2
OTA 0.9991 1.6–36.4 4.8 5.2 2.0 6.8 71.4 (5.2) 1.9 54.8 (1.1) −49.9
ROQ-C 0.9998 0.2–36.1 2.5 2.9 0.6 6.7 32.2 (2.5) 1.9 87.0 (8.0) −31.0
STE 0.9996 0.5–35.9 4.7 5.1 1.2 6.7 80.9 (3.0) 1.9 76.3 (9.1) −56.3
T-2 0.9999 0.4–9.1 0.9 1.1 0.5 1.7 155.2 (1.9) 0.6 85.7 (0.3) −28.8
CPA 0.9998 2.6–450.5 1.1 3.8 7.0 83.7 53.7 (0.3) 23.5 83.4 (5.5) −25.9
AND A1 0.9999 0.1–19.1 1.2 1.3 0.3 3.5 78.2 (2.5) 0.9 97.6 (3.0) −53.0
AOH1 0.9996 2.0–394.7 3.7 5.6 3.5 73.1 66.7 (2.1) 18.6 84.2 (3.0) −89.6
MPA1 0.9999 1.4–33.2 4.1 3.6 1.6 6.1 81.4 (1.8) 1.7 101.0 (1.1) −34.6
PEN A 0.9993 1.0–191.3 1.4 4.0 2.1 35.4 37.8 (0.5) 9.0 56.5 (0.2) −11.4
α-ZOL1 0.9999 2.5–249.2 4.9 9.4 5.7 90.8 95.8 (6.5) 23.2 90.5 (1.7) −3.0
β-ZOL1 0.9999 2.6–256.4.4 4.8 5.2 5.7 93.4 77.9 (5.2) 23.8 108.2 (4.2) −50.0
ZEA1 0.9999 0.5–100.7 4.6 4.8 1.2 18.7 83.4 (5.9) 4.8 103.7 (5.9) −44.0
FUS X 0.9995 2.0–395.3 0.6 0.6 6 73.2 96.4 (0.7) 18.7 109.6 (0.9) 25.0
AF B1 0.9998 0.1–103.5 4.4 10.4 0.3 21.3 103.3 (5.2) 11.4 57.8 (8.9) −65.0
AF B2 1.0000 0.4–25.9 4.7 4.4 1.2 5.3 105.2 (2.9) 2.9 62.5 (7.6) −43.2
AF G1 0.9998 0.1–103.5 6.8 10.1 0.3 21.3 96.5 (1.9) 11.4 49.2 (6.2) −36.3
AF G2 0.9998 0.4–25.9 4.6 4.3 1.2 5.3 118.3 (0.6) 2.9 135.5 (0.4) −30.3
1. negative mode.
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Table 1 shows the determination coefficient (R2) for all analytes using matrix-matched calibration.
R2 values were in all cases higher than 0.9991, showing an almost perfect linearity in the relation
between the signals obtained and the concentration in the corresponding ranges. Both intra-day (n = 3)
and inter-day (n = 3) precisions were calculated and expressed in terms of relative standard deviation
(RSD) obtaining satisfactory values, ranging from 0.2% to 10.4%. The limits of quantification (LOQs)
ranged from 0.3 to 50 ng mL−1.
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To evaluate t e accuracy of the methodology proposed, a mu titoxin r ference mate ial containing
ZEA, DON and fumonisins was extracted. Mixed ration is a complex nd heterogeneous matrix and
there is no related reference material available; therefore, a maize based one was used. The extraction
recoveries achieved were 78.6% in the case of DON and 98.6% for ZEA, endorsing the trueness of the
proposed methodology.
To evaluate the whole sample preparation and chromatographic methodology for the determination
of all 26 mycotoxins, recovery studies were carried out using the same matrix as in the matrix-matched
calibration. The results, expressed in percentages, are shown in Table 1, as well as the relative standard
deviation in each case. Most compounds gave recovery values between 70% and 120%, especially the most
frequently found in this kind of matrix, DON, ZEA, and FB1 and FB2. Only two mycotoxins achieved
recoveries below 60%, at the two spiking levels (Enniatin B1 (ENN B1) and Penitrem A (PEN A)), but
these analytes are not as recurrent and their contents in food/feed are not yet either regulated. The relative
standard deviations were satisfactory since they were always lower than 9%.
ISO 21748:2017 provides recommendations [30] to assess the expanded measurement uncertainty (U).
Thanks to the performance parameters given in Table 1, especially the intra-day and inter-day
precisions, the relative expanded measurement uncertainty (% U) could be calculated. As shown in
Tabl 2 for those 17 mycotoxins th t were detected in the mixed ra ion sample , % U were low r than
15% in all cas s, except for α-ZOL.
2.3. Application to Real Samples
Using the proposed methodology, 97 mixed ration samples collected in one year at 20 different
dairy farms from Galicia (NW Spain) were analyzed. The criteria used for the correct identification of
the analytes, in addition to the retention time, were the parameters given by the high-resolution mass
spectrometry such as the exact mass accuracy, accepting only a 5 ppm error. The isotopic profile of the
peak found as well as the formula proposed by the software for the mass obtained provided valuable
additional information for the identification. Finally, contrasting the high resolution MS/MS spectra
experimentally obtained with the available library spectra enabled a definitive confirmation.
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Table 2. Concentration ranges, average, maximum and minimum concentrations (with relative
expanded uncertainty, U (%)) and occurrence frequency of the 17 mycotoxins found in the 97 mixed
ration samples.
Compounds Concentration (ng g−1) N◦ Positive
Occurrence
Frequency (%)
Average Max Min U (%)
3+15-ADON 426.9 770.0 214.1 13.2 33 33.7
DON 52.8 81.3 36.5 14.1 15 16.3
ENN B 322.0 1305.5 53.1 13.4 49 50.0
FB1 578.8 1453.9 14.0 11.6 95 96.9
FB2 160.6 481.1 13.3 1.1 64 65.3
MAC A 124.3 209.9 46.1 13.6 4 4.1
OTA 5.1 5.1 5.1 11.0 1 1.0
ROQ-C 36.9 59.3 19.6 6.3 4 4.1
STER 8.7 15.3 2.6 10.9 20 20.4
CPA 96.5 257.0 2.6 8.7 22 22.4
AND A 33.3 91.0 8.8 2.8 6 6.1
AOH 126.3 295.4 12.7 12.4 24 24.5
MPA 262.2 3151.4 8.2 7.4 19 19.4
PEN A 159.7 234.5 63.7 9.1 9 9.2
α-ZOL 32.5 50.3 25.3 21.1 28 28.6
β-ZOL 35.3 78.9 8.1 11.0 67 68.4
ZEA 10.2 23.2 3.5 10.2 90 91.8
Figure 3 summarizes the total of positives of each compound found in all samples. Fumonisins
B1 and B2, zearalenone and its metabolite β-zearalenol, cyclopiazonic acid and enniatin B were the
mycotoxins most frequently found. FB1 was detected in 95 samples; ZEA in 90 samples; ENN B in
49 samples and DON in 15 samples. This results are in consonance with other studies published on
mycotoxin occurrence in feed [8,20,31]. All samples exhibited co-occurrence of two or more mycotoxins,
repeatedly zearalenone and fumonisin B1, ZEA-FB1-ENN B and ZEA-FB1-DON. These co-occurrences
are often found in feedstuff, as recent studies show [29,32]. However, the concentrations found in
the mixed ration samples of the present study are much lower than those reported in these previous
studies on maize based feed and silages [26,29,32].
Table 2 collects the concentration ranges and the average values in which the analyzed mycotoxins
were present in the samples. ZEA, DON, FB1, and FB2 concentrations were always lower than the
recommended values in feed intended for dairy cows; 0.5, 5, and 50 mg kg−1, respectively. It should be
noted that 3+15-ADON concentrations were one magnitude order higher than DON ones, with an
occurrence frequency of 34%. As stated by EFSA in 2013 [33], it is important to collect more data on the
incidence of these derivatives to better characterize their potential contribution to the total exposure
to DON.
ENN B showed an average concentration of 0.32 mg kg−1 and reached a maximum content of
1.3 mg kg−1. A particular attention should be paid to this cyclic depsipeptide since a recent EFSA
scientific report, combining an in vivo toxicity and genotoxicity approach, concludes that ENN B poses
a genotoxic hazard [34].
Finally, the screening of non-targeted mycotoxins conducted by implementing a retrospective
approach with the same acquired data files and by contrasting HR MS/MS spectra with those of
the mycotoxin library enabled to identify monocerin, aurofusarin, beauvericin, chlamydosporol,
sambucinol, mevastatin, and two forms of enniantin, enniantins B4 and J1. Two anthraquinone
derivatives, emodin and chrysophanol, were also identified.
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3. Conclusions
The proposed analytical methodology based on QuEChERS with (d)SPE clean-up and HPLC-HRMS
analysis allowed the screening and quantitation of 26 mycotoxins in mixed rations. The full method was
successfully ptimized, and its accuracy was confirmed using a reference aterial, as w ll. Recovery
values were acc ptabl for most analytes, giving good results considering th complexity of the matrix for
a multi-analyte methodology. Matrix-matched calibration was utilized to compensate for matrix effects,
mostly suppressive, except from fumonisins.
The analytical method has been applied to the analysis of 97 samples. Fumonisins B1 (97%)
and B2 (65%), zearalenone (92%), its metabolite β-zearalenol (68%) and enniatin B (50%) were the most
frequently found mycotoxins. All samples presented co-occurrence of two or more mycotoxins, recurrently
zearalenone and fumonisin B1, amongst others. The use of SWATHTM acquisition mode proved to be a
very attractive approach for the unambiguous identification as well as for the accurate quantification of
the target mycotoxins in complex feed samples. Additional screening based on a retrospective approach
enabled the identification of non-targeted mycotoxins, most of them originated from Fusarium fungi.
4. Materials and Methods
4.1. Reagents and Standards
The studied compounds, their molecular formula, exact mass, CAS numbers and structure are
summarized in Table 3. Standards of 3+15-ADON, DON, HT-2, OTA, ROQ-C, T-2, ZEA, AFB1, AFG1,
AFB2, AFG2 were obtained from Biopure (Romer Labs, Tulln, Austria); ENN B, ENN B1, STER, α-ZOL
and β-ZOL from Sigma-Aldrich (Saint Louis, MO, USA); fumonisins FB1 and FB2 from Acros Organics
(New Jersey, USA); MARC A and AND A from Santa Cruz Biotechnology (Dallas, TX, USA); CPA and
MPA from Alpha Aesar (Ward Hill, MA, USA); AOH and PEN A from Cayman Chemical (Ann Harbor,
MI, USA). Acetonitrile, water and methanol (both > 99.95% purity) were provided by Carlo Erba
(Milan, Italy). Formic acid (99%), acetic acid glacial, ammonium formate and ammonium acetate were
all LC-MS grade and were provided by Biosolve (Dieuze, France and Valkenswaard, The Netherlands).
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Table 3. Target mycotoxins: molecular formula, exact mass, CAS number, molecular ion, retention time and structure.
Mycotoxins Acronym Molecular Formula Exact Mass (m/z) CAS Number Molecular Ion RT (min) Structure
3-Acetyl
deoxynivalenol 3-ADON C17H22O7 338.1365 50722-38-8 [M+H]
+ 3.83
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A multitoxin maize reference material (QCM7C1, Biopure, Romer Labs, Tulln, Austria) was used
for checking the extraction method accuracy.
Individual stock solutions for each mycotoxin were prepared in acetonitrile. Further dilutions
and mixtures were prepared in methanol. All solutions were stored at −20 ◦C.
4.2. Sampling and Sample Treatment
Mixed rations for dairy cows in Galicia usually rely on own forages and concentrates, and in
recent years, the ensiled maize proportion is being increasing. Concentrates are mostly a complement
of protein and energy to balance dairy cow rations. In Galicia, these concentrates are made with soya
cake (30%) and rapeseed cake (20%) to increase protein, and with cereals, mainly maize (25%) and
barley (15%), to achieve the cattle energy requirement.
97 mixed ration samples collected in 20 dairy farms between October 2017 and October 2018 in
Galicia (NW Spain). Five hundred grams of the sample was dried for 48 h at 40 ◦C and then put in
vacuum bags and stored at 4 ◦C until their analysis.
4.3. QuEChERS Extraction
Two grams of unifeed samples were weighed and placed in 50 mL falcon tubes with the addition
of 10 mL of water and 10 mL of acetonitrile/formic acid (90:10% v/v). The tubes were placed in an
automated shaker for 1 h at room temperature. Then, a mixture of 0.5 NaSesquihydrate/1g NaCitrate/1g
NaCl/4g MgSO4 (DisQuETM Pouch for CEN, Waters, Milford, USA) was added and the tube was
shaken vigorously by hand for 1 min. After centrifugation (3398× g for 5 min), a portion of the
supernatant was saved for subsequent clean-up.
4.4. Clean-Up Procedure
An Oasis PRiME HLB cartridge (3cc, 150 mg), Waters, Milford, MA, USA) was placed on a vacuum
manifold. Without previous conditioning, after discarding 0.4 mL of supernatant, a 1 mL aliquot
was passed-trough the cartridge and, the collected extract was then transferred to a 2 mL dSPE tube
containing a mixture of sorbents (150 mg MgSO4, 50 mg PSA, 30 mg C18, 30 mg Al-N) (Waters, Milford,
USA). After centrifugation (2 min at 2360× g), a 500 µL aliquot was taken, evaporated under a gentle
nitrogen stream, and reconstituted in 350 µL of methanol.
4.5. HPLC-QTOF Analysis
For LC-HRMS analysis, a HPLC system (Shimadzu Nexera X2) consisting of two high-pressure
pumps (LC-30AD) and a SIL-30AC autosampler was used. HRMS detection was performed by a SCIEX
(Ontario, Canada) TripleTOF® 5600+ equipped with a DuoSprayTM ion source and an Electrospray
Ionization (ESI) probe. The chromatographic separation was achieved with a Kinetex bioZenTM
Peptide XB-C18 (50 × 2.1 mm, 2.6 µm) column from Phenomenex (Torrance, CA, USA), kept at 40 ◦C
with a CTO-30A column oven.
The mobile phase consisted of water (A) and methanol (B), both buffered with 3mM ammonium
formate or ammonium acetate. Formic acid and acetic acid addition (0.1%) was also tested in
combination with its respective buffer.
An 8-min gradient elution profile (10% B to 100% B) was employed reaching a total runtime of 15 min.
The mobile phase flow-rate was kept to 0.25 mL mL−1 and the injection volume was set at 10 µL.
Regarding the HRMS conditions, the source temperature was set at 550 ◦C, the ion source gas at
50 (au, arbitrary units), the curtain gas at 30 (au), and the ion spray voltage floating at 5500 V (−4500 V
in the negative mode).
The HRMS workflow consisted of a Full Scan, using 250 ms as accumulation time and 80 V (−80 V in
negative mode) as the declustering potential in the ESI. Simultaneously, a data independent approach
based on SWATH (Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra) was
performed. A wide mass range (80–850 Da) was divided in 30 mass windows with an accumulation time
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of 35 ms for each one. The cycle time was slightly higher than 1 s, enabling a perfect reconstruction of
any chromatographic peak. The declustering potential was set to 80 V (−80 V in negative mode) and the
collision energy was 40 V (−40 V in negative mode), with an energy spread of 20 V.
SWATH acquisition is a Data Independent Acquisition (DIA) strategy that delivers the complete
picture of a sample. It provides the best method for performing sample analysis, identifying and
quantifying every detectable analyte in a single chromatographic run.
In contrast to traditional mass spectrometry acquisition techniques that rely on Data Dependent
Acquisition (DDA) strategies, SWATH acquisition is not “dependent” upon some pre-set criteria
determined by the abundance of the compound. With SWATH acquisition, every detectable ion,
irrespective of its concentration, is fragmented, identified and quantified to provide the high-resolution
full MS and MS/MS picture for every peak. The data produced by SWATH then contains all the
information that would be acquired in a multitude of different experimental approaches in a single
all-encompassing dataset. Furthermore, SWATH acquisition cycle time does not increase as the number
of target compounds increases.
In terms of post-acquisition, the complete set of data can serve as a digital archive of each sample,
allowing full access to pull out anything that you may be interested in, without the need to re-inject
your samples. Should new hypotheses arise in the future, this feature allows you to re-interrogate the
sample data without re-analyzing the actual sample.
The system was operated by Analyst® 1.7.1 (SCIEX, Ontario, Canada) control software, PeakView®
2.2 (SCIEX, Ontario, Canada) processing software and MultiQuant® 3.0 (SCIEX, Ontario, Canada)
quantitation software. A mycotoxin HR MS/MS spectral library (1.0), containing 288 compounds was
used for identification and confirmation purposes.
As usual, mass accuracy is expressed in ppm, calculated as the relative difference between the
measured mass and the actual mass of each analyte, as follows:
Accuracy (ppm) =
(Measured mass−Actual mass)
Actual mass
∗ 1000000
4.6. Method Validation
The limit of quantification (LOQ) of each analyte was evaluated using the parameters of each
matrix-matched calibration curve and the S/N obtained for the lowest concentration level of each analyte.
The matrix effect was calculated by subtracting the ratio of the slope values of the matrix-matched
calibration curve and the external calibration curve to 1, and expressing it as a relative percentage (%)
(See Table 1).
The mixed ration sample selected for recovery experiments was spiked in triplicate at two
concentration levels (individual values indicated in Table 1). Aliquots of 2 g of fortified mixed ration
samples were let interacting for 20 h at ambient temperature and protected from natural and artificial
light exposure. Recovery values were given as the ratio of the signal obtained for these fortified
samples and the response of the corresponding concentration level in the matrix-matched standards.
ISO 21748:2017 provides recommendations [30] to assess the expanded measurement uncertainty
(U) which was calculated (see following equations) by multiplying the combined standard uncertainty
(uc) by a coverage factor (k). At a confidence level of 95%, this k factor was set to two. The standard
uncertainty (uc) formulae combined the variance of the inter-day precision (S2R) and the uncertainty
associated with the bias (ubias2). The latter was calculated using the number of replicates (n), the
Toxins 2020, 12, 206 18 of 20
number of different conditions (p), the variance of the intra-day precision (S2r) and the variance of the
inter-day precision (S2R).
ubias =
√√
(
S2R − (1−
1
n
)S2r
p
)
uc =
√
S2R + ubias2
U = ky uc
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/12/3/206/s1,
Table S1: Regression equations for matrix-matched calibrations of the target mycotoxins in positive mode, using
different mobile phase compositions. Table S2: Regression equations for matrix-matched calibrations of some
target mycotoxins in negative mode, using different mobile phase compositions.
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